<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00337415</url>
  </required_header>
  <id_info>
    <org_study_id>0354-004</org_study_id>
    <nct_id>NCT00337415</nct_id>
  </id_info>
  <brief_title>MK0354 Clinical Efficacy and Tolerability Study (0354-004)</brief_title>
  <official_title>Proprietary Information - Exploratory (Non-Confirmatory) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <brief_summary>
    <textblock>
      A Research Study to Evaluate the Effectiveness and Tolerability of MK0354 vs Placebo (an
      inactive look alike pill) in Lipid (fat) Altering in Patients with dyslipidemia (a disorder
      of lipids in the blood)

      This is an early phase trial and some specific protocol information is proprietary and not
      publicly available at this time. (Full information is available to trial participants).
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">August 2006</completion_date>
  <primary_completion_date type="Actual">August 2006</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proprietary information - exploratory (non-confirmatory) trial</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>proprietary information - exploratory (non-confirmatory) trial</measure>
  </secondary_outcome>
  <enrollment type="Actual">65</enrollment>
  <condition>Dyslipidemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MK0354</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is between 18 and 75 years of age

          -  You have taken a statin or other lipid modifying therapy in the last 6-8 weeks

          -  You have lipid lab values outside of the range specified in the protocol

        Exclusion Criteria:

          -  Patient is a woman who is pregnant or nursing a child

          -  Patient is a woman who is taking hormonal birth-control

          -  You are a woman who is planning to donate eggs during the study

          -  You plan to give blood during the study or have given within the last 8 weeks

          -  You are a woman who is having menopausal hot flashes or are taking medications to
             prevent menopausal hot flashes

          -  You have a known intolerance to or you are allergic to niacin

          -  You have any of the following medical conditions:

          -  Poorly controlled or newly diagnosed diabetes (within the last 3 months)

          -  Thyroid disease (hypothyroidism or hyperthyroidism)

          -  A history of stroke, heart attack, coronary bypass surgery, angioplasty, unstable
             angina or similar heart and artery procedures in the past 3 months

          -  History of hemorrhagic stroke or other non-traumatic hemorrhage

          -  Peptic ulcer disease in the last 3 months

          -  An occurrence of gout within the last year and you are not currently taking
             allopurinol

          -  Cancer (except for successfully treated skin cancer)

          -  HIV positive

          -  You have a history of drug/alcohol abuse within the last year

          -  You consume more than 2 drinks of alcohol per day

          -  You do not have access to a telephone

          -  You take medications that are not allowed in this study. The study doctor or staff
             will discuss this with you.

          -  Patient has participated in a study with an investigational drug within the last 30
             days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2006</study_first_submitted>
  <study_first_submitted_qc>June 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2006</study_first_posted>
  <last_update_submitted>May 15, 2015</last_update_submitted>
  <last_update_submitted_qc>May 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

